Showing results (11-20 of 212) with videos related to
Sort By:
Pageof 22
Bone and Mineral|October 1, 1987
An analysis of bone structure in patients with hip fractureP J Uitewaal, P Lips, J C NetelenbosHormone Research|January 1, 1990
Growth hormone (replacement) therapy in adults: bone and calcium metabolismE A van der Veen, J C NetelenbosEndocrinology|October 1, 1996
Growth hormone induces tyrosine phosphorylation of annexin I in rat osteosarcoma cellsJ P Salles, J C Netelenbos, M C SlootwegAngiology|February 1, 1993
The risk of emergency intestinal bleeding among users of acenocoumarin: a population-based cohort studyT J Cleophas, P Tavenier, M G NiemeyerNederlands Tijdschrift Voor Geneeskunde|February 9, 2006
[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis]W F Lems, N A T Hamdy, J C NetelenbosNederlands Tijdschrift Voor Tandheelkunde|May 1, 1995
[Osteoporosis and jaw bone reduction]M A van Waas, F G Corten, J C NetelenbosClinical Nephrology|March 25, 2005
Risk factors determining active urinary stone formation in patients with urolithiasisJ C Netelenbos, P J G Zwijnenburg, P M ter WeeJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1989
The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexualsP Lips, H Asscheman, P Uitewaal, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patientsW H Hackeng, P Lips, J C Netelenbos, et al.Bone and Mineral|December 1, 1993
Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidismL van Doorn, P Lips, J C Netelenbos, et al.Pageof 22